REDWOOD CITY, Calif., Aug. 8, 2012 /PRNewswire/ -- Cardica, Inc. (Nasdaq: CRDC) today announced that Bernard A. Hausen, M.D., Ph.D., the company’s president and chief executive officer, is scheduled to present a corporate overview and update at the 2012 Wedbush PacGrow Life Sciences Management Access Conference on Tuesday, August 14 at 1:20 p.m. Eastern time.
To access the live and subsequently archived webcasts of the presentations, go to the Investor Relations section of the company’s website at http://www.cardica.com/. Please connect to the website at least 15 minutes prior to the presentation to allow for any necessary software downloads.
About Cardica
Cardica designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures. Cardica’s technology portfolio is intended to minimize operating time and enable minimally-invasive and robot-assisted surgeries. Cardica manufactures and markets its automated anastomosis systems, the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System for coronary artery bypass graft (CABG) surgery, and has shipped over 41,500 units throughout the world. In addition, Cardica is developing the Cardica MicroCutter XCHANGE 30, a cartridge-based microcutter device with a 5 millimeter shaft diameter, and the Cardica MicroCutter XPRESS 30, a true multi-fire laparoscopic stapling device designed to be used in a variety of procedures, including bariatric, colorectal, thoracic and general surgery. The Cardica MicroCutter XCHANGE 30 and XPRESS 30 products require 510(k) review and are not yet commercially available in the U.S.
SOURCE Cardica, Inc.
